# Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

> **NCT04763200** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Abiomed Inc.** · enrollment: 1252 (estimated)

## Conditions studied

- Left Ventricular Dysfunction
- Coronary Artery Disease

## Interventions

- **DEVICE:** Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®
- **DEVICE:** IABP Intra-aortic balloon pump

## Key facts

- **NCT ID:** NCT04763200
- **Lead sponsor:** Abiomed Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-13
- **Primary completion:** 2026-03
- **Final completion:** 2027-10
- **Target enrollment:** 1252 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04763200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04763200, "Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04763200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*